The global eClinical Solutions market is driven by increasing R&D expenditure in Pharmaceutical and Biotechnology companies, rising government funding and grants for clinical trials, growing adoption of eClinical Solutions to streamline R&D and clinical trial activity. However, high cost related to eClinical Solutions and lack of awareness & reluctance to adopt new technology is likely to restrain the market to certain extent. The global eClinical Solutions market is segmented by product, mode of delivery, clinical trials, end users and region. On the basis of Product, the eClinical Solutions market is segmented into Clinical Trial Management Systems (CTMS), Clinical Analytics Platform, Clinical Data Integration Platform, Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trail Master File (eTMF), Safety Solutions, and Other eClinical Solutions. The EDC and CDMS segment is estimated to account for the largest market share of the global eClinical Solutions market.
Market Industry Reports (MIR) has published a new report titled “eClinical Solutions Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global eClinical Solutions Market is estimated to be over US$ 4.0 Bn in 2017. It is anticipated to grow at a CAGR of 13.0% from 2019 to 2030.
Major Key Players of the eClinical Solutions Market are:
Oracle, EClinical Solutions, Parexel International Corporation, Bioclinica, Inc., Datatrak International Inc., ERT Clinical, Medidata solutions, Merger Healthcare Incorporated, Omnicomm Systems, Inc. and NextGen Healthcare
Oracle, EClinical Solutions, Parexel International Corporation, Bioclinica, Inc., Datatrak International Inc., ERT Clinical, Medidata solutions, Merger Healthcare Incorporated, Omnicomm Systems, Inc. and NextGen Healthcare
No comments:
Post a Comment